Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3687)
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,624
Price
$78.94
Total Value
$365.00K
Shares Held After
708,719
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,376
Price
$78.38
Total Value
$421.37K
Shares Held After
713,343
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
675
Price
$485.52
Total Value
$327.72K
Shares Held After
36,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
934
Price
$484.92
Total Value
$452.91K
Shares Held After
37,456
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,748
Price
$483.92
Total Value
$1.33M
Shares Held After
38,390
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,103
Price
$482.57
Total Value
$532.27K
Shares Held After
41,138
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,363
Price
$481.93
Total Value
$1.14M
Shares Held After
42,241
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
477
Price
$480.92
Total Value
$229.40K
Shares Held After
44,604
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
2,145
Price
$18.46
Total Value
$39.60K
Shares Held After
216,637
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
747
Price
$107.67
Total Value
$80.43K
Shares Held After
128,918
% of Holdings
0.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,000
Price
$106.60
Total Value
$106.60K
Shares Held After
129,665
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,500
Price
$104.74
Total Value
$157.12K
Shares Held After
130,665
% of Holdings
1.1%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
12,616
Price
$6.44
Total Value
$81.27K
Shares Held After
84,092
% of Holdings
13.0%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
14,783
Price
$6.44
Total Value
$95.23K
Shares Held After
94,201
% of Holdings
13.6%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
7,205
Price
$6.44
Total Value
$46.41K
Shares Held After
25,271
% of Holdings
22.2%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
18,894
Price
$6.44
Total Value
$121.71K
Shares Held After
97,859
% of Holdings
16.2%
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
48,913
Price
$6.44
Total Value
$315.09K
Shares Held After
222,018
% of Holdings
18.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.12
Total Value
$164.80K
Shares Held After
913,839
% of Holdings
4.2%
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
12,348
Price
$6.44
Total Value
$79.54K
Shares Held After
70,327
% of Holdings
14.9%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
10,905
Price
$6.44
Total Value
$70.25K
Shares Held After
69,067
% of Holdings
13.6%
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
1,655
Price
$4.52
Total Value
$7.48K
Shares Held After
1,442,131
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
996
Price
$350.00
Total Value
$348.60K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$348.79
Total Value
$231.60K
Shares Held After
996
% of Holdings
40.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
10,100
Price
$77.54
Total Value
$783.15K
Shares Held After
708,719
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,900
Price
$76.94
Total Value
$761.67K
Shares Held After
718,819
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
509
Price
$32.74
Total Value
$16.66K
Shares Held After
105,211
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
2,485
Price
$32.07
Total Value
$79.69K
Shares Held After
105,720
% of Holdings
2.3%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
232
Price
$32.85
Total Value
$7.62K
Shares Held After
105,706
% of Holdings
0.2%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
1,547
Price
$32.11
Total Value
$49.67K
Shares Held After
105,938
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
110
Price
$32.90
Total Value
$3.62K
Shares Held After
111,226
% of Holdings
0.1%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,635
Price
$32.14
Total Value
$52.55K
Shares Held After
111,336
% of Holdings
1.4%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
970
Price
$6.69
Total Value
$6.49K
Shares Held After
612,919
% of Holdings
0.2%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
3,471
Price
$2.24
Total Value
$7.78K
Shares Held After
761,158
% of Holdings
0.5%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
6,035
Price
$8.54
Total Value
$51.54K
Shares Held After
377,802
% of Holdings
1.6%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
200
Price
$68.94
Total Value
$13.79K
Shares Held After
211,148
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$67.88
Total Value
$6.79K
Shares Held After
211,348
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
1,299
Price
$66.85
Total Value
$86.84K
Shares Held After
211,448
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
1,420
Price
$65.83
Total Value
$93.48K
Shares Held After
212,747
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,481
Price
$64.88
Total Value
$160.97K
Shares Held After
214,167
% of Holdings
1.1%
aTyr Pharma, Inc. (ATYR)
Broadfoot Jill Marie — Chief Financial Officer
Shares
1,558
Price
$0.98
Total Value
$1.52K
Shares Held After
37,296
% of Holdings
4.0%
aTyr Pharma, Inc. (ATYR)
DENYES NANCY — General Counsel
Shares
1,118
Price
$0.98
Total Value
$1.09K
Shares Held After
33,124
% of Holdings
3.3%
aTyr Pharma, Inc. (ATYR)
Shukla Sanjay — Director
Shares
3,745
Price
$0.98
Total Value
$3.66K
Shares Held After
153,553
% of Holdings
2.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
9,794
Price
$25.81
Total Value
$252.75K
Shares Held After
80,651
% of Holdings
10.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
2,602
Price
$45.02
Total Value
$117.14K
Shares Held After
12,546
% of Holdings
17.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.13
Total Value
$5.65K
Shares Held After
273,866
% of Holdings
1.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,087
Price
$43.29
Total Value
$47.06K
Shares Held After
22,885
% of Holdings
4.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
19,076
Price
$43.29
Total Value
$825.85K
Shares Held After
164,580
% of Holdings
10.4%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
3,217
Price
$19.69
Total Value
$63.34K
Shares Held After
55,588
% of Holdings
5.5%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
1,608
Price
$19.69
Total Value
$31.66K
Shares Held After
51,326
% of Holdings
3.0%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
2,654
Price
$19.69
Total Value
$52.26K
Shares Held After
52,934
% of Holdings
4.8%
Showing 2401–2450 of 3687 transactions (page 49 of 74)